Active Biotech AB (publ) belongs to the Health Care sector. Filings by its managers are published through Finansinspektionen. Between 18 October 2025 and 18 October 2026, 2 insiders published 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (890 companies, median 7 filings), a count of 3 filings is below the norm.
There has been no open-market purchase by an insider of Active Biotech AB (publ) for at least a year. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade.
Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
FY ended December 2025 · cache
3 of 3 declarations
Active Biotech AB (publ) is a Swedish biopharmaceutical company focused on developing treatments for serious diseases. It is listed on the Stockholm Stock Exchange under the ticker XSTO.
Purchases our model currently ranks for the recommendations list.
All recommendations